• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于机器学习算法的甲状腺乳头状癌变异型预后模型与治疗结局。

Prognostic Models Using Machine Learning Algorithms and Treatment Outcomes of Papillary Thyroid Carcinoma Variants.

机构信息

Research Associate, King Hussein Cancer Center, Amman, Jordan.

Internship, Princess Basma Teaching Hospital, Irbid, Jordan.

出版信息

Cancer Rep (Hoboken). 2024 Dec;7(12):e70071. doi: 10.1002/cnr2.70071.

DOI:10.1002/cnr2.70071
PMID:39614618
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11607134/
Abstract

BACKGROUND

Hürthle cell (HCC) and columnar cell variants (CCV) are rare subtypes of thyroid cancer.

AIMS

This study used machine learning (ML) to evaluate treatment effectiveness and develop prognostic models.

METHODS

Chi-square tests, Kaplan-Meier curves, log-rank tests, and Cox regression were used. Five ML algorithms constructed prognostic models predicting 5-year survival, validated using the AUC of the ROC curve.

RESULTS

Among 3690 patients, 3180 had CCV and 510 had HCC. ML models showed metastasis, surgery + RT, and age were significant factors for HCC, while the N component of TNM, metastasis, and tumor size were significant for CCV.

CONCLUSION

This study offers a comprehensive approach for treating and assessing prognosis in PTC variants. The ML models developed offer practical tools for personalized clinical decision-making.

摘要

背景

Hurthle 细胞(HCC)和柱状细胞变异型(CCV)是甲状腺癌的罕见亚型。

目的

本研究使用机器学习(ML)评估治疗效果并开发预后模型。

方法

采用卡方检验、Kaplan-Meier 曲线、对数秩检验和 Cox 回归。构建了 5 种 ML 算法的预后模型,预测 5 年生存率,通过 ROC 曲线的 AUC 进行验证。

结果

在 3690 名患者中,3180 名患有 CCV,510 名患有 HCC。ML 模型显示转移、手术+RT 和年龄是 HCC 的显著因素,而 TNM 的 N 成分、转移和肿瘤大小是 CCV 的显著因素。

结论

本研究为 PTC 变异体的治疗和预后评估提供了一种综合方法。所开发的 ML 模型为个性化临床决策提供了实用工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1494/11607134/294554b8f764/CNR2-7-e70071-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1494/11607134/02a9976e1c9c/CNR2-7-e70071-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1494/11607134/fe122e1c7bc0/CNR2-7-e70071-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1494/11607134/ca05bee1bd4c/CNR2-7-e70071-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1494/11607134/3651b0d1d903/CNR2-7-e70071-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1494/11607134/eff8f9649918/CNR2-7-e70071-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1494/11607134/76f2ce1f73f5/CNR2-7-e70071-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1494/11607134/294554b8f764/CNR2-7-e70071-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1494/11607134/02a9976e1c9c/CNR2-7-e70071-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1494/11607134/fe122e1c7bc0/CNR2-7-e70071-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1494/11607134/ca05bee1bd4c/CNR2-7-e70071-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1494/11607134/3651b0d1d903/CNR2-7-e70071-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1494/11607134/eff8f9649918/CNR2-7-e70071-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1494/11607134/76f2ce1f73f5/CNR2-7-e70071-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1494/11607134/294554b8f764/CNR2-7-e70071-g001.jpg

相似文献

1
Prognostic Models Using Machine Learning Algorithms and Treatment Outcomes of Papillary Thyroid Carcinoma Variants.基于机器学习算法的甲状腺乳头状癌变异型预后模型与治疗结局。
Cancer Rep (Hoboken). 2024 Dec;7(12):e70071. doi: 10.1002/cnr2.70071.
2
Treatment strategies and predicting lymph node metastasis in elderly patients with papillary thyroid microcarcinoma.老年甲状腺微小乳头状癌患者的治疗策略及淋巴结转移预测
Medicine (Baltimore). 2021 May 7;100(18):e25811. doi: 10.1097/MD.0000000000025811.
3
Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study.第八版肿瘤-淋巴结-转移分期系统中 N1b 亚分期对甲状腺乳头状癌的修正:一项多机构队列研究。
Oral Oncol. 2018 Nov;86:48-52. doi: 10.1016/j.oraloncology.2018.09.008. Epub 2018 Sep 13.
4
Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: A multicenter cohort study.第八版肿瘤-淋巴结-转移分期系统提高了对甲状腺乳头状癌而非滤泡状癌的生存预测能力:一项多中心队列研究。
Oral Oncol. 2018 Dec;87:97-103. doi: 10.1016/j.oraloncology.2018.10.029. Epub 2018 Oct 26.
5
Ultrasound-based nomogram to predict the recurrence in papillary thyroid carcinoma using machine learning.基于超声的列线图,使用机器学习预测甲状腺乳头状癌的复发。
BMC Cancer. 2024 Jul 7;24(1):810. doi: 10.1186/s12885-024-12546-6.
6
Overall survival is improved with total thyroidectomy and radiation for male patients and patients older than 55 with T2N0M0 Stage 1 classic papillary thyroid cancer.对于 T2N0M0 期 1 型经典乳头状甲状腺癌的男性患者和年龄大于 55 岁的患者,行甲状腺全切除术和放疗可改善总生存率。
Surgery. 2022 Jan;171(1):197-202. doi: 10.1016/j.surg.2021.08.025. Epub 2021 Oct 16.
7
Radioactive iodine does not improve overall survival for patients with aggressive variants of papillary thyroid carcinoma less than 2 cm.放射性碘对 2 厘米以下侵袭性甲状腺乳头状癌变异型患者的总生存率无改善。
Surgery. 2022 Jan;171(1):203-211. doi: 10.1016/j.surg.2021.05.054. Epub 2021 Aug 10.
8
Prognostic nutritional index predicts lateral lymph node metastasis and recurrence free survival in papillary thyroid carcinoma.预后营养指数预测甲状腺乳头状癌的侧颈部淋巴结转移和无复发生存。
BMC Cancer. 2024 Aug 22;24(1):1039. doi: 10.1186/s12885-024-12801-w.
9
Extrathyroidal extension predicts negative clinical outcomes in papillary thyroid cancer.甲状腺外侵犯预示着甲状腺乳头状癌的不良临床结局。
Surgery. 2021 Jan;169(1):2-6. doi: 10.1016/j.surg.2020.04.003. Epub 2020 Jul 16.
10
Predicting recurrence of papillary thyroid cancer using the eighth edition of the AJCC/UICC staging system.使用第八版 AJCC/UICC 分期系统预测甲状腺乳头状癌的复发。
Br J Surg. 2019 Jun;106(7):889-897. doi: 10.1002/bjs.11145. Epub 2019 Apr 23.

引用本文的文献

1
Artificial intelligence in focus: assessing awareness and perceptions among medical students in three private Syrian universities.聚焦人工智能:评估叙利亚三所私立大学医学生的认知与看法
BMC Med Educ. 2025 May 29;25(1):801. doi: 10.1186/s12909-025-07396-0.
2
Personalized treatment strategies for breast adenoid cystic carcinoma: A machine learning approach.乳腺腺样囊性癌的个性化治疗策略:一种机器学习方法。
Breast. 2025 Feb;79:103878. doi: 10.1016/j.breast.2025.103878. Epub 2025 Jan 13.

本文引用的文献

1
The 5 edition of WHO classification of tumors of endocrine organs: changes in the diagnosis of follicular-derived thyroid carcinoma.《世界卫生组织内分泌器官肿瘤分类》第 5 版:滤泡源性甲状腺癌诊断的变化。
Endocrine. 2023 Jun;80(3):470-476. doi: 10.1007/s12020-023-03336-4. Epub 2023 Mar 25.
2
Differentiated thyroid carcinoma: An update.分化型甲状腺癌:最新进展
Best Pract Res Clin Endocrinol Metab. 2023 Jan;37(1):101687. doi: 10.1016/j.beem.2022.101687. Epub 2022 Aug 12.
3
Development and validation of a prognostic nomogram for Hürthle cell thyroid carcinoma: a SEER-based study.
甲状腺嗜酸细胞癌预后列线图的开发与验证:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Gland Surg. 2022 Mar;11(3):535-544. doi: 10.21037/gs-21-781.
4
Follicular and Hurthle Cell Carcinoma: Comparison of Clinicopathological Features and Clinical Outcomes.滤泡性和 Hurthle 细胞癌:临床病理特征和临床结局的比较。
Thyroid. 2022 Mar;32(3):245-254. doi: 10.1089/thy.2021.0424.
5
Oncocytic Papillary Thyroid Carcinoma and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake, and Response to Radioactive Iodine Therapy, and Outcome.嗜酸细胞性甲状腺乳头状癌和嗜酸细胞性甲状腺低分化癌:临床特征、摄取、对放射性碘治疗的反应和结局。
Front Endocrinol (Lausanne). 2021 Dec 16;12:795184. doi: 10.3389/fendo.2021.795184. eCollection 2021.
6
Machine learning methods for automated classification of tumors with papillary thyroid carcinoma-like nuclei: A quantitative analysis.机器学习方法在具有甲状腺乳头状癌样核的肿瘤自动分类中的应用:一项定量分析。
PLoS One. 2021 Sep 22;16(9):e0257635. doi: 10.1371/journal.pone.0257635. eCollection 2021.
7
Hürthle Cell Carcinoma of the Thyroid Gland: Systematic Review and Meta-analysis.甲状腺 Hurthle 细胞癌:系统评价和荟萃分析。
Adv Ther. 2021 Oct;38(10):5144-5164. doi: 10.1007/s12325-021-01876-7. Epub 2021 Aug 22.
8
Genomic profile of columnar cell variant of papillary thyroid carcinoma.甲状腺乳头状癌柱状细胞变体的基因组图谱。
Histopathology. 2021 Oct;79(4):491-498. doi: 10.1111/his.14374. Epub 2021 Jun 15.
9
Machine learning-based prediction model using clinico-pathologic factors for papillary thyroid carcinoma recurrence.基于临床病理因素的机器学习预测模型用于甲状腺乳头状癌复发。
Sci Rep. 2021 Mar 2;11(1):4948. doi: 10.1038/s41598-021-84504-2.
10
Thyroid Hürthle Cell Carcinoma: Clinical, Pathological, and Molecular Features.甲状腺许特莱细胞癌:临床、病理及分子特征
Cancers (Basel). 2020 Dec 23;13(1):26. doi: 10.3390/cancers13010026.